Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2024 04:00 ET | Source: iOmx Therapeutics AG

iOmx Therapeutics to present new data on lead programs and I/O target screening platform at AACR 2024

OMX-0407: clinical-stage, spectrum selective SIK kinase inhibitor with dual effect on tumor growth and immune evasionIOMX-0675: best-in-class antibody targeting immunosuppressive receptors LILRB1...